ES2154633T3 - Procedimiento y composicion de prevencion de la enfermedad de lyme. - Google Patents

Procedimiento y composicion de prevencion de la enfermedad de lyme.

Info

Publication number
ES2154633T3
ES2154633T3 ES92111713T ES92111713T ES2154633T3 ES 2154633 T3 ES2154633 T3 ES 2154633T3 ES 92111713 T ES92111713 T ES 92111713T ES 92111713 T ES92111713 T ES 92111713T ES 2154633 T3 ES2154633 T3 ES 2154633T3
Authority
ES
Spain
Prior art keywords
lyme
disease
prevention
procedure
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92111713T
Other languages
English (en)
Inventor
Ian Dr Livey
Friedrich Dr Prof Dorner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2154633(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of ES2154633T3 publication Critical patent/ES2154633T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UN INMUNOGENO EFECTIVO CONTRA LA BORRELIOSIS DE LYME EN LOS MAMIFEROS QUE COMPRENDE UNA PROTEINA PC HOMOGENEA DEL "B. BURGDORFERI" Y UN EXCIPIENTE FISIOLOGICAMENTE ACEPTABLE.
ES92111713T 1991-07-11 1992-07-09 Procedimiento y composicion de prevencion de la enfermedad de lyme. Expired - Lifetime ES2154633T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72724591A 1991-07-11 1991-07-11
US82416192A 1992-01-22 1992-01-22
US07/903,580 US6221363B1 (en) 1991-07-11 1992-06-25 Vaccine for the prevention of lyme disease

Publications (1)

Publication Number Publication Date
ES2154633T3 true ES2154633T3 (es) 2001-04-16

Family

ID=27419096

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92111713T Expired - Lifetime ES2154633T3 (es) 1991-07-11 1992-07-09 Procedimiento y composicion de prevencion de la enfermedad de lyme.

Country Status (17)

Country Link
US (2) US6221363B1 (es)
EP (1) EP0522560B2 (es)
JP (1) JP2611095B2 (es)
AT (1) ATE198489T1 (es)
AU (1) AU660178B2 (es)
CA (1) CA2073486C (es)
CZ (1) CZ280743B6 (es)
DE (1) DE69231619T3 (es)
DK (1) DK0522560T4 (es)
ES (1) ES2154633T3 (es)
FI (1) FI107334B (es)
HR (1) HRP950174B1 (es)
HU (1) HU219772B (es)
MX (1) MX9204078A (es)
NO (1) NO304546B1 (es)
SI (1) SI9200143B (es)
SK (1) SK217292A3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
US6303129B1 (en) * 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
ES2114687T3 (es) * 1993-04-29 1998-06-01 Immuno Ag Formulacion inmunogena a base de antigenos ospc, destinada para la prevencion y para el tratamiento de la enfermedad de lyme y procedimientos de recombinacion para la preparacion de estos antigenos.
US6248562B1 (en) 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
DK0757556T3 (da) 1994-04-11 2006-10-02 Wyeth Corp Borrelia Burgdorferi-bakterin
US6087097A (en) * 1994-05-12 2000-07-11 Mayo Foundation For Medical Education And Research PCR detection of Borrelia burgdorferi
ZA964896B (en) * 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
US6165774A (en) * 1995-09-22 2000-12-26 Connaught Laboratories Limited Parainfluenza virus glycoproteins and vaccines
EP0880543A4 (en) * 1995-10-26 2000-08-02 Rhode Island Education ANTIGENS AS VACCINE CANDIDATES FROM SPIROCHETE (BORRELIA BURGDORFERI) OF LIVE DISEASE INDUCED BY A SALT OF A TICK VECTOR (IXODES SCAPULARIS)
US6045804A (en) * 1996-03-07 2000-04-04 Mayo Foundation For Medical Educational Research Method for detecting B. burgdorferi infection
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
GB9811219D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel process
AU4654500A (en) * 1999-04-21 2000-11-02 Boston Medical Center Corporation Prevention, diagnosis and treatment of lyme disease
EP1194559B1 (en) 1999-06-18 2006-09-20 Research Foundation Of State University Of New York Groups of borrelia burgdorferi that cause lyme disease in humans
DE60131982T2 (de) 2000-08-18 2008-12-11 Brookhaven Science Associates Llc Veränderte borrelia burgdorferi ospa
US8277852B2 (en) * 2002-01-25 2012-10-02 Akzo Nobel Surface Chemistry Llc Bioactive botanical cosmetic compositions and processes for their production
US7442391B2 (en) 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
EP2491939B1 (en) * 2004-01-12 2017-09-20 ISP Investments LLC Bioactive compositions from theacea plants and processes for their production and use
KR20100126845A (ko) 2006-01-19 2010-12-02 도요 세이칸 가부시키가이샤 커플러 및 연료 전지용의 연료 카트리지
WO2008057396A2 (en) * 2006-11-03 2008-05-15 Schering-Plough Ltd. Canine lyme disease vaccine
CA2677023C (en) * 2007-02-22 2016-08-30 Baxter International Inc. Method of purification of hydrophobic proteins
EP2274616A1 (en) * 2008-04-22 2011-01-19 The Research Foundation of State University of New York Borrelia burgdorferi cell envelope protein array
CA2781110C (en) * 2009-11-17 2018-07-31 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
TWI815599B (zh) 2011-04-22 2023-09-11 美商惠氏有限責任公司 與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
KR102451333B1 (ko) * 2018-10-22 2022-10-06 주식회사 엘지화학 마이크로비드 및 그 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
US4601903A (en) * 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US4888276A (en) * 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
DE3818013A1 (de) 1988-05-27 1989-11-30 Henkel Kgaa Gewebeweichmachungsmittel
IT1223777B (it) * 1988-08-18 1990-09-29 Gevipi Ag Rubinetto a due uscite con inversore a depressione
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
CA2072008C (en) * 1989-12-22 2003-01-28 Renate Fuchs Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains
DE3942728C1 (en) 1989-12-22 1991-05-23 Mikrogen Molekularbiologische Entwicklungs-Gmbh, 8000 Muenchen, De New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
EP0524958B1 (en) 1990-03-05 1996-09-18 THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE Antigenic proteins of borrelia burgdorferi
IE20010565A1 (en) * 1990-07-06 2002-07-10 Wyeth Corp Vaccine Against Lyme Disease and A Challenge Model for Evaluating Vaccine Efficiency

Also Published As

Publication number Publication date
FI923175A (fi) 1993-01-12
DK0522560T4 (da) 2007-04-10
SI9200143A (en) 1993-03-31
US5530103A (en) 1996-06-25
HUT66525A (en) 1994-12-28
CA2073486C (en) 2002-07-02
DE69231619T2 (de) 2001-05-31
HU219772B (hu) 2001-07-30
JP2611095B2 (ja) 1997-05-21
DK0522560T3 (da) 2001-03-05
EP0522560A2 (en) 1993-01-13
HRP950174A2 (en) 1997-08-31
ATE198489T1 (de) 2001-01-15
SK279250B6 (sk) 1998-08-05
EP0522560B2 (en) 2006-12-20
JPH072696A (ja) 1995-01-06
SK217292A3 (en) 1998-08-05
SI9200143B (en) 2001-06-30
NO304546B1 (no) 1999-01-11
CA2073486A1 (en) 1993-01-12
DE69231619T3 (de) 2007-07-12
FI107334B (fi) 2001-07-13
AU1934992A (en) 1993-01-14
EP0522560B1 (en) 2001-01-03
EP0522560A3 (en) 1994-05-11
AU660178B2 (en) 1995-06-15
NO922746L (no) 1993-01-12
HRP950174B1 (en) 2001-08-31
MX9204078A (es) 1993-04-01
HU9202289D0 (en) 1992-10-28
US6221363B1 (en) 2001-04-24
FI923175A0 (fi) 1992-07-09
CZ280743B6 (cs) 1996-04-17
CZ217292A3 (en) 1993-01-13
DE69231619D1 (de) 2001-02-08
NO922746D0 (no) 1992-07-10

Similar Documents

Publication Publication Date Title
ES2154633T3 (es) Procedimiento y composicion de prevencion de la enfermedad de lyme.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
NL300098I2 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
DE69228747D1 (de) Medizinische/chirurgische vorrichtungen
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
IT9048557A0 (it) Perfezionata composizione adesiva per protesi dentarie e procedimento per la sua preparazione.
IT1256652B (it) Procedimento per la preparazione di una composizione farmaceutica che abbassa selettivamente il livello di lipidi del sangue
DK0491085T3 (da) Tandlæge-patientstol
SE8804628D0 (sv) New compounds
IL84844A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
ITTO910664A0 (it) Procedimento e dispositivo per la guida dello slittone di una pressa.
BR9509975A (pt) Formulação farmacêutica
DK0466833T3 (da) Insekticide og synergistiske miticide midler
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
ITMI922571A0 (it) Procedimento per la preparazione di un cassetto a stantuffo nonche' dispositivo per l'attuazione del procedimento
ATE199495T1 (de) Pharmazeutische zubereitung zur direktverpressung
SE9502219D0 (sv) Novel medical use
IT1092132B (it) Vite autofilettante nonche' procedimento per la sua fabbricazione e ganascia di cilindratura per l'attuazione del procedimento
IT1277348B1 (it) Composizione farmaceutica per abbassare la pressione del sangue e procedimento per la sua preparazione
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
YU68592A (sh) Kompozicija za sprečavanje lajmske bolesti i postupak za dobijanje
IT8722622A0 (it) Procedimento perfezionato di ripristino della continuita' del filo nella roccatura e dispositivi per la sua realizzazione.
MX9101421A (es) Composiciones farmaceuticas que comprenden naproxen y sodio de naproxen e hidrocloruro de pseudoefedrina.
ITTN960015V0 (it) "schema anatomico del viso di una persona" per l'esecuzione completa ottimale di un occhiale da vista senza la presenza fisica della

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522560

Country of ref document: ES